• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXSB2400122 注射用重组人凝血因子Ⅷ-Fc融合蛋白 Recombinant Human Coagulation Factor VIII-Fc Fusion Protein Lyophilized Biological Products(2.4) Supplementary Application 2024-10-13 Chengdu Rongsheng Pharmaceuticals Co Ltd view
JYSB2200166 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2022-08-24 Bayer Healthcare LLC view
JYSB2300036 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2023-02-23 Bayer Healthcare LLC view
CYSB2101190 人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2021-09-17 Shanxi Kangbao Biological Product Co Ltd view
JYSZ2500014 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products License Renew 2025-06-12 Novo Nordisk (China) Pharmaceuticals Co Ltd;Novo Nordisk A/S view
CXSS2200013 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products(3.4) New Drug Application 2022-02-07 Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group view
CXSL2400210 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products(3.4) New Drug Application 2024-04-03 Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group view
JXSS2200007 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products(3.1) Import Drug Application 2022-01-26 Octapharma Ab Sweden;Sichuan Sinco Pharmaceutical Co Ltd view
JYSZ2100537 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products License Renew 2021-12-17 Baxalta Manufacturing Sàrl;Takeda Manufacturing Austria AG;Takeda (China) International Trading Co Ltd view
CYSB2101002 人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2021-03-06 Shandong Taibang Biological Products Co Ltd view
CXSL2300639 注射用重组人凝血因子Ⅷ-Fc融合蛋白 Recombinant Human Coagulation Factor VIII-Fc Fusion Protein Lyophilized Biological Products(2.4) New Drug Application 2023-09-21 Chengdu Rongsheng Pharmaceuticals Co Ltd view
JYSB2200164 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2022-08-24 Bayer Healthcare LLC view
JYSB2200092 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2022-06-09 Pfizer Europe Ma Eeig;Wyeth Farma SA view
CYSB2400134 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products(原10) Supplementary Application 2024-05-24 SinoCelltech Ltd view
CYSB2200010 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products(原10) Supplementary Application 2022-01-10 SinoCelltech Ltd view
JYSB2200094 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2022-06-09 Pfizer Europe Ma Eeig;Wyeth Farma SA view
JXSS2200003 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products(3.1) Import Drug Application 2022-01-26 Octapharma Ab Sweden;Sichuan Sinco Pharmaceutical Co Ltd view
JYSB2400249 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2024-12-04 Baxalta Manufacturing Sàrl;Takeda Manufacturing Austria AG view
CXSS2200054 人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products(3.4) New Drug Application 2022-05-27 Shenzhen Weiguang Biological Products Co Ltd view
JYSB1200214 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2012-08-27 拜耳医药保健有限公司 Bayer Healthcare Company Ltd;Bayer Healthcare LLC Approval Completed-Pending Certificated view